{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:34:50Z","timestamp":1782588890125,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s12072-018-9918-2","type":"journal-article","created":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T22:08:11Z","timestamp":1544566091000},"page":"84-90","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5857-9391","authenticated-orcid":false,"given":"Umair","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany B.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Cholankeril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,12]]},"reference":[{"issue":"375","key":"9918_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1056\/NEJMra1504367","volume":"25","author":"PS Ge","year":"2016","unstructured":"Ge PS, Runyon BA. Treatment of patients with cirrhosis. N Engl J Med 2016;25(375):767\u2013777","journal-title":"N Engl J Med"},{"issue":"6","key":"9918_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/1756283X11413002","volume":"4","author":"M Cohen-Naftaly","year":"2011","unstructured":"Cohen-Naftaly M, Friedman SL. Current status of novel antifibrotic therapies in patients with chronic liver disease. Ther Adv Gastroenterol 2011;4(6):391\u2013417","journal-title":"Ther Adv Gastroenterol."},{"issue":"167","key":"9918_CR3","doi-asserted-by":"publisher","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman SL, Sheppard D, Duffield JS, et al. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 2013;5(167):167sr1","journal-title":"Sci Transl Med."},{"issue":"32","key":"9918_CR4","doi-asserted-by":"publisher","first-page":"E2165","DOI":"10.1073\/pnas.1209182109","volume":"109","author":"G Sitia","year":"2012","unstructured":"Sitia G, Aiolfi R, Di Lucia P, et al. Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci USA 2012;109(32):E2165\u2013E2172","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"9918_CR5","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1053\/j.gastro.2014.08.038","volume":"147","author":"S Yoshida","year":"2014","unstructured":"Yoshida S, Ikenaga N, Liu SB, et al. Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology 2014;147(6):1378\u20131392","journal-title":"Gastroenterology"},{"issue":"6","key":"9918_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/carcin\/15.6.1279","volume":"15","author":"A Denda","year":"1994","unstructured":"Denda A, Tang Q, Endoh T, et al. Prevention by acetylsalicylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, l-Amino acid-defined diet in rats. Carcinogenesis 1994;15(6):1279\u20131283","journal-title":"Carcinogenesis."},{"issue":"11","key":"9918_CR7","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/gut.2007.144550","volume":"57","author":"K Fujita","year":"2008","unstructured":"Fujita K, Nozaki Y, Wada K, et al. Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease. Gut 2008;57(11):1583\u20131591","journal-title":"Gut"},{"issue":"1","key":"9918_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jat.1638","volume":"32","author":"E Ch\u00e1vez","year":"2012","unstructured":"Ch\u00e1vez E, Castro-S\u00e1nchez L, Shibayama M, et al. Effects of acetyl salycilic acid and ibuprofen in chronic liver damage induced by CCl4. J Appl Toxicol 2012;32(1):51\u201359","journal-title":"J Appl Toxicol"},{"issue":"4","key":"9918_CR9","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/hep.510240417","volume":"24","author":"IR Wanless","year":"1996","unstructured":"Wanless IR, Belgiorno J, Huet PM. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole. Hepatology 1996;24(4):855\u2013864","journal-title":"Hepatology."},{"issue":"4","key":"9918_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151(4):264\u2013269, W64","journal-title":"Ann Intern Med."},{"issue":"7414","key":"9918_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557\u2013560","journal-title":"BMJ"},{"issue":"6","key":"9918_CR12","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/apt.13515","volume":"43","author":"ZG Jiang","year":"2016","unstructured":"Jiang ZG, Feldbr\u00fcgge L, Tapper EB, et al. Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. Aliment Pharmacol Ther 2016;43(6):734\u2013743","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"9918_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.clinre.2014.07.004","volume":"38","author":"A Poujol-Robert","year":"2014","unstructured":"Poujol-Robert A, Bo\u00eblle P-Y, Conti F, et al. Aspirin may reduce liver fibrosis progression: evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation. Clin Res Hepatol Gastroenterol 2014;38(5):570\u2013576","journal-title":"Clin Res Hepatol Gastroenterol."},{"issue":"68","key":"9918_CR14","doi-asserted-by":"publisher","first-page":"S582","DOI":"10.1016\/S0168-8278(18)31424-7","volume":"1","author":"A Singh","year":"2018","unstructured":"Singh A, Gosai F, Lopez R, et al. Regular aspirin use is not protective against advanced fibrosis in type-2 diabetics with biopsy-proven nonalcoholic fatty liver disease. J Hepatol 2018;1(68):S582\u2013S583","journal-title":"J Hepatol"},{"key":"9918_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1254","author":"K Schwarzkopf","year":"2018","unstructured":"Schwarzkopf K, Bojunga J, R\u00fcschenbaum S. Use of antiplatelet agents is inversely associated with liver fibrosis in patients with cardiovascular disease. Hepatol Commun 2018. \n                    https:\/\/doi.org\/10.1002\/hep4.1254\n                    \n                  .","journal-title":"Hepatol Commun."},{"issue":"1","key":"9918_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1160\/TH09-03-0177","volume":"103","author":"JB Muhlestein","year":"2010","unstructured":"Muhlestein JB. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients. Thromb Haemost 2010;103(1):71\u201382","journal-title":"Thromb Haemost"},{"issue":"4","key":"9918_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","volume":"145","author":"A Brouquet","year":"2009","unstructured":"Brouquet A, Benoist S, Julie C, et al. Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146 patients with colorectal metastases. Surgery 2009;145(4):362\u2013371","journal-title":"Surgery."},{"issue":"6","key":"9918_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0002-9343(03)00436-4","volume":"115","author":"R Segal","year":"2003","unstructured":"Segal R, Lubart E, Leibovitz A, Berkovitch M, Habot B, Yaron M, et al. Early and late effects of low-dose aspirin on renal function in elderly patients. Am J Med 2003;115(6):462\u2013466","journal-title":"Am J Med"},{"issue":"9","key":"9918_CR19","doi-asserted-by":"publisher","first-page":"762.e6","DOI":"10.1016\/j.cgh.2011.05.020","volume":"9","author":"A Lanas","year":"2011","unstructured":"Lanas A, Wu P, Medin J, Mills EJ. Low doses of acetylsalicylic acid increase risk of gastrointestinal bleeding in a meta-analysis. Clin Gastroenterol Hepatol 2011;9(9):762.e6\u2013768.e6","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"9918_CR20","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/lt.25067","volume":"24","author":"SS Patel","year":"2018","unstructured":"Patel SS, Guzman LA, Lin F-P, Pence T, Reichman T, John B, et al. Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation. Liver Transpl 2018;24(7):872\u2013880","journal-title":"Liver Transpl"},{"issue":"10","key":"9918_CR21","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/ajg.2017.170","volume":"112","author":"S Kamal","year":"2017","unstructured":"Kamal S, Khan MA, Seth A, Cholankeril G, Gupta D, Singh U, et al. Beneficial effects of statins on the rates of hepatic fibrosis, hepatic decompensation, and mortality in chronic liver disease: a systematic review and meta-analysis. Am J Gastroenterol 2017;112(10):1495\u2013505","journal-title":"Am J Gastroenterol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-018-9918-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-018-9918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T19:18:52Z","timestamp":1576091932000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-018-9918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["9918"],"URL":"https:\/\/doi.org\/10.1007\/s12072-018-9918-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,12]]},"assertion":[{"value":"6 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Umair Iqbal, Brittany B. Dennis, Andrew A. Li, George Cholankeril, Donghee Kim, Muhammad Ali Khan and Aijaz Ahmed declare no conflict of interest, including financial and\/or material support for the preparation of this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}